Cargando…
Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling
Broad-spectrum antiviral agents that are effective against many viruses are difficult to develop, as the key molecules, as well as the biochemical pathways by which they cause infection, differ largely from one virus to another. This was more strongly highlighted by the COVID-19 pandemic, which foun...
Autores principales: | Zagaliotis, Panagiotis, Petrou, Anthi, Mystridis, George A., Geronikaki, Athina, Vizirianakis, Ioannis S., Walsh, Thomas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325261/ https://www.ncbi.nlm.nih.gov/pubmed/35887353 http://dx.doi.org/10.3390/ijms23148006 |
Ejemplares similares
-
Thiazole/Thiadiazole/Benzothiazole Based Thiazolidin-4-One Derivatives as Potential Inhibitors of Main Protease of SARS-CoV-2
por: Petrou, Anthi, et al.
Publicado: (2022) -
Physiologically Based Pharmacokinetic Modelling and Simulation to Predict the Plasma Concentration Profile of Doxorubicin
por: Mystridis, George A., et al.
Publicado: (2022) -
Novel Thiazolidin-4-ones as Potential Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
por: Petrou, Anthi, et al.
Publicado: (2019) -
4,5-Diaryl 3(2H)Furanones: Anti-Inflammatory Activity and Influence on Cancer Growth
por: Semenok, Dmitrii, et al.
Publicado: (2019) -
Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile
por: Haroun, Michelyne, et al.
Publicado: (2023)